Safety Study of Hepatitis E Vaccine (HEV239)
Clinical trial NCT03827395 · COMPLETED
Trial details
- NCT number
- NCT03827395
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-12
- Primary completion
- 2020-08-28
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.